Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. 2008

Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
Nordic Bioscience A/S, Herlev Hovedgade 207, DK-2730 Herlev, Denmark. mk@nordicbioscience.com

BACKGROUND Physiological and pathophysiological cartilage turnover may coexist in articular cartilage. The distinct enzymatic processes leading to irreversible cartilage damage, compared with those needed for continuous self-repair and regeneration, remain to be identified. We investigated the capacity of repair of chondrocytes by analyzing their ability to initiate an anabolic response subsequent to three different levels of catabolic stimulation. METHODS Cartilage degradation was induced by oncostatin M and tumour necrosis factor in articular cartilage explants for 7, 11, or 17 days. The catabolic period was followed by 2 weeks of anabolic stimulation (insulin growth factor-I). Cartilage formation was assessed by collagen type II formation (PIINP). Cartilage degradation was measured by matrix metalloproteinase (MMP) mediated type II collagen degradation (CTX-II), and MMP and aggrecanase mediated aggrecan degradation by detecting the 342FFGVG and 374ARGSV neoepitopes. Proteoglycan turnover, content, and localization were assessed by Alcian blue. RESULTS Catabolic stimulation resulted in increased levels of cartilage degradation, with maximal levels of 374ARGSV (20-fold induction), CTX-II (150-fold induction), and 342FFGVG (30-fold induction) (P < 0.01). Highly distinct protease activities were found with aggrecanase-mediated aggrecan degradation at early stages, whereas MMP-mediated aggrecan and collagen degradation occurred during later stages. Anabolic treatment increased proteoglycan content at all time points (maximally, 250%; P < 0.001). By histology, we found a complete replenishment of glycosaminoglycan at early time points and pericellular localization at an intermediate time point. In contrast, only significantly increased collagen type II formation (200%; P < 0.01) was observed at early time points. CONCLUSIONS Cartilage degradation was completely reversible in the presence of high levels of aggrecanase-mediated aggrecan degradation. After induction of MMP-mediated aggrecan and collagen type II degradation, the chondrocytes had impaired repair capacity.

UI MeSH Term Description Entries
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002358 Cartilage, Articular A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact. Articular Cartilage,Articular Cartilages,Cartilages, Articular
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D020782 Matrix Metalloproteinases A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components. MMP,MMPs,Matrix Metalloproteinase,Metalloproteinase, Matrix,Metalloproteinases, Matrix
D024043 Collagen Type II A fibrillar collagen found predominantly in CARTILAGE and vitreous humor. It consists of three identical alpha1(II) chains. Collagen Type II, alpha1 Chain,Collagen Type II, alpha1 Subunit,Collagen alpha1(II),Procollagen Type II,Type II Collagen,Type II Procollagen,Collagen, Type II,Procollagen, Type II

Related Publications

Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
January 1997, Arthritis and rheumatism,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
July 1997, The Journal of clinical investigation,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
June 2002, Current opinion in pharmacology,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
October 2000, The Journal of biological chemistry,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
July 2017, Arthritis research & therapy,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
November 1998, The Journal of biological chemistry,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
January 1992, International journal of tissue reactions,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
May 1998, Osteoarthritis and cartilage,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
March 1998, The Journal of biological chemistry,
Morten A Karsdal, and Suzi H Madsen, and Claus Christiansen, and Kim Henriksen, and Amanda J Fosang, and Bodil C Sondergaard
September 2003, Osteoarthritis and cartilage,
Copied contents to your clipboard!